Results 211 to 220 of about 20,478,757 (338)
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck +12 more
wiley +1 more source
Future burden of MASLD in the United States: A state-level forecasting study, 2022-2050. [PDF]
Suenghataiphorn T +4 more
europepmc +1 more source
Strength through diversity: how cancers thrive when clones cooperate
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken +3 more
wiley +1 more source
Any Safe Harbor in a Storm: SESTA-FOSTA and the Future of § 230 of the Communications Decency Act
Charles Matula
openalex +1 more source
Strategies for small dairy farmers to be profitable and competitive in the future
Bob Cropp
openalex +2 more sources
Temporal orientation and the teaching life cycle: pathways linking teachers' growth, recognition, and performance across two studies. [PDF]
Meng L, Briscioli B.
europepmc +1 more source
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source
Future projections of European maize yields using AquaCrop with an adaptive growing season.
Busschaert L +4 more
europepmc +1 more source

